Unigene Laboratories Inc Sample Contracts

WHEREAS:
Registration Rights Agreement • January 19th, 2001 • Unigene Laboratories Inc • Medicinal chemicals & botanical products • Illinois
AutoNDA by SimpleDocs
EXHIBIT Q
Registration Rights Agreement • January 10th, 1997 • Unigene Laboratories Inc • Medicinal chemicals & botanical products • Delaware
WHEREAS:
Common Stock Purchase Agreement • April 27th, 2001 • Unigene Laboratories Inc • Medicinal chemicals & botanical products • Illinois
and
Rights Agreement • December 23rd, 2002 • Unigene Laboratories Inc • Medicinal chemicals & botanical products • New York
EXHIBIT 10.19 EXECUTION COPY AMENDED AND RESTATED SECURITIES PURCHASE AGREEMENT by and among
Securities Purchase Agreement • January 10th, 1997 • Unigene Laboratories Inc • Medicinal chemicals & botanical products • New York
WHEREAS:
Registration Rights Agreement • May 10th, 2001 • Unigene Laboratories Inc • Medicinal chemicals & botanical products • Illinois
ARTICLE I PURCHASE AND SALE OF STOCK
Stock Purchase Agreement • August 4th, 1997 • Unigene Laboratories Inc • Medicinal chemicals & botanical products • New York
WHEREAS:
Registration Rights Agreement • October 10th, 2003 • Unigene Laboratories Inc • Medicinal chemicals & botanical products • Illinois
WHEREAS:
Registration Rights Agreement • April 27th, 2001 • Unigene Laboratories Inc • Medicinal chemicals & botanical products • Illinois
WHEREAS:
Registration Rights Agreement • May 10th, 2001 • Unigene Laboratories Inc • Medicinal chemicals & botanical products • Illinois
REGISTRATION RIGHTS AGREEMENT
Registration Rights Agreement • October 6th, 2008 • Unigene Laboratories Inc • Medicinal chemicals & botanical products • Illinois

This REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of September 30, 2008, is entered into by and among Unigene Laboratories, Inc., a Delaware corporation (the “Company”), and the lender(s) listed on the Schedule of Buyers attached hereto (each, a “Buyer” and collectively, the “Buyers”).

AutoNDA by SimpleDocs
EMPLOYMENT AGREEMENT
Employment Agreement • October 3rd, 2012 • Unigene Laboratories Inc • Medicinal chemicals & botanical products • New Jersey

This EMPLOYMENT AGREEMENT (“Agreement”), dated as of September 27, 2012, is entered into by and between Unigene Laboratories, Inc., a Delaware corporation (the “Company”), and Nozer Mehta (the “Executive”).

WHEREAS:
Common Stock Purchase Agreement • October 10th, 2003 • Unigene Laboratories Inc • Medicinal chemicals & botanical products • Illinois
EMPLOYMENT AGREEMENT
Employment Agreement • June 12th, 2012 • Unigene Laboratories Inc • Medicinal chemicals & botanical products • New Jersey

This EMPLOYMENT AGREEMENT (“Agreement”), dated as of June 8, 2012 (the “Effective Date”), is entered into by and between Unigene Laboratories, Inc., a Delaware corporation (the “Company”), and Ashleigh Palmer (the “Executive”).

WITNESSETH:
Director Stock Option Agreement • April 18th, 2003 • Unigene Laboratories Inc • Medicinal chemicals & botanical products • New Jersey
FIRST AMENDMENT TO EMPLOYMENT AGREEMENT
Employment Agreement • March 16th, 2009 • Unigene Laboratories Inc • Medicinal chemicals & botanical products

THIS FIRST AMENDMENT to the Employment Agreement, dated as of January 1, 2000 (the “Agreement”) is made as of this 22nd day of December, 2008 by and between UNIGENE LABORATORIES, INC. (the “Company”) and Warren Levy (the “Executive”).

REGISTRATION RIGHTS AGREEMENT
Registration Rights Agreement • March 22nd, 2006 • Unigene Laboratories Inc • Medicinal chemicals & botanical products • New York

REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of March 17, 2006, by and among Unigene Laboratories Inc., a Delaware corporation, with headquarters located at 110 Little Falls Road, Fairfield, New Jersey 07004 (the “Company”), and the investors listed on the Schedule of Buyers attached hereto (each, a “Buyer” and collectively, the “Buyers”).

CONFIDENTIAL SEPARATION AGREEMENT AND GENERAL RELEASE
Confidential Separation Agreement and General Release • August 9th, 2012 • Unigene Laboratories Inc • Medicinal chemicals & botanical products

THIS CONFIDENTIAL SEPARATION AGREEMENT AND GENERAL RELEASE (the “Separation Agreement”) is made and entered into by and between David Moskowitz (“Employee”) and Unigene Laboratories, Inc. (“Unigene” or the “Company”).

UNIGENE LABORATORIES, INC. AMENDED AND RESTATED SECURED PROMISSORY NOTE
Subordination Agreement • October 6th, 2008 • Unigene Laboratories Inc • Medicinal chemicals & botanical products • New Jersey

UCC-1 Financing Statement filed in New Jersey on 6/26/01 in favor of GE Capital Colonial Pacific Leasing (assignee of lessor Genesis Commercial Capital, LLC) regarding: Equipment/Lease No. 01328-01

February 1, 2006
Compensation Agreement • March 16th, 2009 • Unigene Laboratories Inc • Medicinal chemicals & botanical products • New Jersey

The purpose of this letter agreement (this “Agreement”) is to set out our agreement on your compensation deferral arrangement commencing January 1, 2006 (the “Effective Date”) and memorializes the Unigene Deferred Compensation Plan adopted pursuant to a resolution of the Board of Directors of Unigene Laboratories, Inc. (the “Company”) on December 14, 2005.

AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT
Registration Rights Agreement • March 17th, 2010 • Unigene Laboratories Inc • Medicinal chemicals & botanical products • Illinois

• broker-dealers may agree with the selling stockholders to sell a specified number of such shares at a stipulated price per share;

Contract
Unigene Laboratories Inc • March 20th, 2008 • Medicinal chemicals & botanical products • New Jersey

Portions of this Exhibit were omitted and filed separately with the Secretary of the Commission pursuant to an application for confidential treatment filed with the Commission pursuant to Rule 406 under the Securities Act of 1933. Such omissions are designated as ***.

Time is Money Join Law Insider Premium to draft better contracts faster.